一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

Lamin A/C (phospho Ser22)兔多抗,Lamin A/C (phospho Ser22) Rabbit Polyclonal Antibody
  • Lamin A/C (phospho Ser22)兔多抗,Lamin A/C (phospho Ser22) Rabbit Polyclonal Antibody

Lamin A/C (phospho Ser22) Rabbit Polyclonal Antibody | 兔多抗 | EnkiLife恩璣生命

價(jià)格 詢價(jià)
包裝 1支
最小起訂量 1支
發(fā)貨地 湖北
更新日期 2026-05-06
微信洽談

產(chǎn)品詳情

中文名稱:Lamin A/C (phospho Ser22)兔多抗英文名稱:Lamin A/C (phospho Ser22) Rabbit Polyclonal Antibody
品牌: EnkiLife產(chǎn)地: 中國(guó)
保存條件: Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.產(chǎn)品類別: 抗體
用途: 科研是否進(jìn)口:
2026-05-06 Lamin A/C (phospho Ser22)兔多抗 Lamin A/C (phospho Ser22) Rabbit Polyclonal Antibody 1支/RMB EnkiLife 中國(guó) Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. 抗體

產(chǎn)品概述

產(chǎn)品名稱(Product Name)

Lamin A/C (phospho Ser22) Rabbit Polyclonal Antibody

描述(Description)

Rabbit Polyclonal Antibody

宿主(Host)

Rabbit

應(yīng)用(Application)

WB,IHC-P,IF-P,IF-F,ICC/IF,ELISA

種屬反應(yīng)性(Reactivity)

Human,Mouse,Rat

 

產(chǎn)品性能

偶聯(lián)物(Conjugation)

Unconjugated

修飾(Modification)

Phospho Antibody

同種型(Isotype)

IgG

克隆(Clonality)

Polyclonal

形式(Form)

Liquid

存放說(shuō)明(Storage)

Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.

儲(chǔ)存溶液(Buffer)

Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% New type preservative N.

純化方式(Purification)

Affinity purification

 

免疫原

基因名(Gene Name)

LMNA

別名(Alternative Names)

LMNA; LMN1; Prelamin-A/C

基因ID(Gene ID)

4000

蛋白ID(SwissProt ID)

P02545

 

產(chǎn)品應(yīng)用

稀釋比(Dilution Ratio)

WB 1:500-1:2000, IHC-P 1:100-1:300, ELISA 1:5000, IF-P/IF-F/ICC/IF 1:50-200

蛋白分子量(Molecular Weight)

74kDa

 

研究背景

lamin A/C(LMNA) Homo sapiens The nuclear lamina consists of a two-dimensional matrix of proteins located next to the inner nuclear membrane. The lamin family of proteins make up the matrix and are highly conserved in evolution. During mitosis, the lamina matrix is reversibly disassembled as the lamin proteins are phosphorylated. Lamin proteins are thought to be involved in nuclear stability, chromatin structure and gene expression. Vertebrate lamins consist of two types, A and B. Alternative splicing results in multiple transcript variants. Mutations in this gene lead to several diseases: Emery-Dreifuss muscular dystrophy, familial partial lipodystrophy, limb girdle muscular dystrophy, dilated cardiomyopathy, Charcot-Marie-Tooth disease, and Hutchinson-Gilford progeria syndrome. [provided by RefSeq, Apr 2012],disease:Defects in LMNA are a cause of Emery-Dreifuss muscular dystrophy type 2 (EDMD2) [MIM:181350]. EDMD2 is an autosomal dominant disorder characterized by slowly progressive muscle wasting and weakness, early contractures of the elbows Achilles tendons and spine, and cardiomyopathy associated with cardiac conduction defects.,disease:Defects in LMNA are a cause of Emery-Dreifuss muscular dystrophy type 3 (EDMD3) [MIM:604929]. EDMD3 is an autosomal recessive disorder characterized by early contractures, muscle wasting and weakness and cardiomyopathy.,disease:Defects in LMNA are a cause of familial partial lipodystrophy type 2 (FPLD2) [MIM:151660]; also known as familial partial lipodystrophy Dunnigan type. FPLD2 is an autosomal dominant disorder characterized by marked loss of subcutaneous adipose tissue from the extremities and trunk but by excess fat deposition in the head and neck. Frequently associated with profound insulin resistance, dyslipidemia, and diabetes.,disease:Defects in LMNA are a cause of generalized lipoatrophy associated with diabetes, hepatic steatosis, hypertrophic cardiomyopathy and leukomelanodermic papules (LDHCP) [MIM:608056]. LDHCP is a disorder characterized by acquired generalized lipoatrophy with metabolic alterations, massive liver steatosis, distinctive cutaneous manifestations, and cardiac abnormalities involving both endocardium and myocardium.,disease:Defects in LMNA are a cause of lethal tight skin contracture syndrome [MIM:275210]; also called restrictive dermopathy (RD). Lethal tight skin contracture syndrome is a rare disorder mainly characterized by intrauterine growth retardation, tight and rigid skin with erosions, prominent superficial vasculature and epidermal hyperkeratosis, facial features (small mouth, small pinched nose and micrognathia), sparse/absent eyelashes and eyebrows, mineralization defects of the skull, thin dysplastic clavicles, pulmonary hypoplasia, multiple joint contractures and an early neonatal lethal course. Liveborn children usually die within the first week of life. The overall prevalence of consanguineous cases suggested an autosomal recessive inheritance.,disease:Defects in LMNA are a cause of tendinous calcinosis arthropathy and progeroid features (TCAPF) [MIM:611618]. This disorder consists of an autosomal recessive arthropathy syndrome affecting predominantly the distal femora and proximal tibia in the knees with tendinous calcifications, associated with progeroide appearance, such as pinched nose and micrognathia, cataract, alopecia, generalized lipodystrophy and sclerodermatous skin.,disease:Defects in LMNA are a cause of Werner syndrome (WRN) [MIM:277700]. WRN is an autosomal, recessively inherited, segmental progeroid syndrome, in which multiple aspects (or segments) of aging phenotypes seem to be entailed. The features of Werner syndrome are scleroderma-like skin changes, especially in the extremities, cataract, subcutaneous calcification, premature arteriosclerosis, diabetes mellitus, and a wizened and prematurely aged facies.,disease:Defects in LMNA are the cause of cardiomyopathy dilated type 1A (CMD1A) [MIM:115200]. Dilated cardiomyopathy is a disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death.,disease:Defects in LMNA are the cause of Charcot-Marie-Tooth disease type 2B1 (CMT2B1) [MIM:605588]. CMT2B1 is a form of Charcot-Marie-Tooth disease, the most common inherited disorder of the peripheral nervous system. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathy or CMT1, and primary peripheral axonal neuropathy or CMT2. Neuropathies of the CMT2 group are characterized by signs of axonal regeneration in the absence of obvious myelin alterations, normal or slightly reduced nerve conduction velocities, and progressive distal muscle weakness and atrophy. CMT2B1 inheritance is autosomal recessive.,disease:Defects in LMNA are the cause of heart-hand syndrome Slovenian type [MIM:610140]. Heart-hand syndrome (HHS) is a clinically and genetically heterogeneous disorder characterized by the co-occurrence of a congenital cardiac disease and limb malformations.,disease:Defects in LMNA are the cause of Hutchinson-Gilford progeria syndrome (HGPS) [MIM:176670]. HGPS is a rare genetic disorder characterized by features reminiscent of marked premature aging.,disease:Defects in LMNA are the cause of limb-girdle muscular dystrophy type 1B (LGMD1B) [MIM:159001]. LGMD1B is an autosomal dominant degenerative myopathy with age-related atrioventricular cardiac conduction disturbances, dilated cardiomyopathy, and the absence of early contractures. LGMD1B is characterized by slowly progressive skeletal muscle weakness of the hip and shoulder girdles. Muscle biopsy shows mild dystrophic changes.,disease:Defects in LMNA are the cause of mandibuloacral dysplasia with type A lipodystrophy (MADA) [MIM:248370]. Mandibuloacral dysplasia (MAD) is a rare autosomal recessive disorder characterized by mandibular and clavicular hypoplasia, acroosteolysis, delayed closure of the cranial suture, joint contractures, and types A or B patterns of lipodystrophy. Type A lipodystrophy observed in MADA, is characterized by fat loss restricted to the extremities.,function:Lamins are components of the nuclear lamina, a fibrous layer on the nucleoplasmic side of the inner nuclear membrane, which is thought to provide a framework for the nuclear envelope and may also interact with chromatin. Lamin A and C are present in equal amounts in the lamina of mammals.,miscellaneous:The structural integrity of the lamina is strictly controlled by the cell cycle, as seen by the disintegration and formation of the nuclear envelope in prophase and telophase, respectively.,miscellaneous:There are three types of lamins in human cells: A, B, and C.,PTM:Increased phosphorylation of the lamins occurs before envelope disintegration and probably plays a role in regulating lamin associations.,PTM:The C-terminal 18 residues are removed by proteolytic cleavage in isoform A. Proteolytic cleavage requires prior farnesylation and absence of farnesylation blocks cleavage.,similarity:Belongs to the intermediate filament family.,subunit:Homodimer of lamin A and lamin C. Interacts with lamin-associated polypeptides IA, IB and TMPO-alpha, RB1 and with emerin. Interacts with SREBF1, SREBF2 and TMEM43 (By similarity). Proteolytically processed isoform A interacts with NARF.,

 

研究領(lǐng)域

Hypertrophic cardiomyopathy (HCM);Arrhythmogenic right ventricular cardiomyopathy (ARVC);Dilated cardiomyopathy;

關(guān)鍵字: LMNA;Lamin;A/C;(phospho;Ser22);Rabbit;Polyclonal;Antibody;一抗

公司簡(jiǎn)介

武漢恩璣生命科技有限公司(EnkiLife)是一家深耕生命科學(xué),專注細(xì)胞生物學(xué)和免疫學(xué)科研試劑的研發(fā)、生產(chǎn)與銷售的生物技術(shù)企業(yè),在全球100多個(gè)國(guó)家和地區(qū)開(kāi)展業(yè)務(wù),致力于為科研工作者提供高質(zhì)量的產(chǎn)品和卓越的客戶服務(wù),推動(dòng)生命科學(xué)的發(fā)展。 EnkiLife的產(chǎn)品線涵蓋細(xì)胞系、原代細(xì)胞、細(xì)胞培養(yǎng)基、血清、細(xì)胞檢測(cè)試劑盒、重組靶點(diǎn)蛋白、細(xì)胞因子、重組抗體、ELISA試劑盒、生化試劑盒等,并提供技術(shù)服務(wù)與定制開(kāi)發(fā),覆蓋了生命科學(xué)研究的各大關(guān)鍵領(lǐng)域,包括細(xì)胞生物學(xué)、癌癥、免疫學(xué)、神經(jīng)科學(xué)、心血管疾病、干細(xì)胞、表觀遺傳學(xué)、內(nèi)分泌、蛋白質(zhì)組學(xué)、代謝組學(xué)等,全方位滿足您的實(shí)驗(yàn)需求,讓您享受科研的樂(lè)趣! 公司現(xiàn)已建立四大技術(shù)平臺(tái): EnCyto?細(xì)胞培養(yǎng)及檢測(cè)平臺(tái):擁有細(xì)胞系庫(kù)(500+)、原代細(xì)胞庫(kù)(500+)、基礎(chǔ)培養(yǎng)基和完全培養(yǎng)基(1200+) EnkiPro?重組蛋白平臺(tái):現(xiàn)貨產(chǎn)品2000+,可提供定制化表達(dá)服務(wù) EnAb?重組抗體平臺(tái):重組兔單抗(3000+),可提供定制化和標(biāo)記服務(wù) EnKits?試劑盒開(kāi)發(fā)平臺(tái):可提供優(yōu)質(zhì)的ELISA試劑盒、配套試劑、抗體對(duì)、生化試劑盒等相關(guān)產(chǎn)品 EnkiLife在生產(chǎn)管理方面引入ISO9001質(zhì)量管理體系和信息化、自動(dòng)化的管理工具,擁有高效穩(wěn)定的交付能力,與全球知名品牌建立了緊密的合作。 EnkiLife始終堅(jiān)持以技術(shù)創(chuàng)新為驅(qū)動(dòng),以匠心鑄就品質(zhì),以品質(zhì)服務(wù)客戶。 我們期待與更多的全球科研工作者和企業(yè)攜手合作,共同推動(dòng)生命科學(xué)領(lǐng)域的進(jìn)步與發(fā)展。
成立日期 2024-08-02 (2年) 注冊(cè)資本 271萬(wàn)人民幣
員工人數(shù) 10-50人 年?duì)I業(yè)額 ¥ 100萬(wàn)-300萬(wàn)
主營(yíng)行業(yè) 生化試劑,抗體,細(xì)胞培養(yǎng),癌癥研究,細(xì)胞生物學(xué) 經(jīng)營(yíng)模式 工廠,試劑,定制,服務(wù)
  • 武漢恩璣生命科技有限公司
VIP 1年
  • 公司成立:2年
  • 注冊(cè)資本:271萬(wàn)人民幣
  • 企業(yè)類型:有限責(zé)任公司(自然人投資或控股)
  • 主營(yíng)產(chǎn)品:細(xì)胞系/原代細(xì)胞/培養(yǎng)基/基因編輯/功能檢測(cè);重組蛋白/抗體;標(biāo)記試劑盒;WB/IHC/TSA/ELISA試劑盒
  • 公司地址:東湖新技術(shù)開(kāi)發(fā)區(qū)高新大道666號(hào)C6棟
詢盤

Lamin A/C (phospho Ser22) Rabbit Polyclonal Antibody | 兔多抗 | EnkiLife恩璣生命相關(guān)廠家報(bào)價(jià)

產(chǎn)品名稱 價(jià)格   公司名稱 報(bào)價(jià)日期
詢價(jià)
碧云天生物技術(shù)有限公司
2026-06-09
詢價(jià)
VIP6年
上海冠導(dǎo)生物工程有限公司
2026-06-11
¥4543
武漢艾美捷科技有限公司
2026-06-09
內(nèi)容聲明:
以上所展示的信息由商家自行提供,內(nèi)容的真實(shí)性、準(zhǔn)確性和合法性由發(fā)布商家負(fù)責(zé)。 商家發(fā)布價(jià)格指該商品的參考價(jià)格,并非原價(jià),該價(jià)格可能隨著市場(chǎng)變化,或是由于您購(gòu)買數(shù)量不同或所選規(guī)格不同而發(fā)生變化。最終成交價(jià)格,請(qǐng)咨詢商家,以實(shí)際成交價(jià)格為準(zhǔn)。請(qǐng)意識(shí)到互聯(lián)網(wǎng)交易中的風(fēng)險(xiǎn)是客觀存在的
主頁(yè) | 企業(yè)會(huì)員服務(wù) | 廣告業(yè)務(wù) | 聯(lián)系我們 | 舊版入口 | 中文MSDS | CAS Index | 常用化學(xué)品CAS列表 | 化工產(chǎn)品目錄 | 新產(chǎn)品列表 |投訴中心
Copyright ? 2008 ChemicalBook 京ICP備07040585號(hào)  京公海網(wǎng)安備110108000080號(hào)  All rights reserved.
平舆县| 油尖旺区| 广宁县| 桃园县| 赤城县| 乐山市| 汾阳市| 安阳县| 买车| 舞钢市| 九江市| 兴文县| 改则县| 明溪县| 青海省| 南江县| 扶绥县| 巴里| 宝丰县| 方城县| 科尔| 灵丘县| 鹤庆县| 大厂| 泾阳县| 天门市| 雅江县| 平江县| 新宁县| 汤原县| 洛扎县| 镇坪县| 保山市| 象州县| 海城市| 武隆县| 定兴县| 香河县| 浦东新区| 东乌珠穆沁旗| 诸暨市|